homocysteine has been researched along with alprostadil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biondi, ML; Marasini, B; Massarotti, M | 1 |
| Akdemir, I; Gursu, F; Kaplan, M; Kilic, N; Ozveren, F; Tiftikci, M; Topsakal, C | 1 |
2 other study(ies) available for homocysteine and alprostadil
| Article | Year |
|---|---|
Homocysteine and vascular diseases.
Topics: alpha-Cyclodextrins; Alprostadil; Cyclodextrins; Drug Administration Schedule; Folic Acid; Homocysteine; Humans; Infusions, Intravenous; Raynaud Disease; Scleroderma, Systemic; von Willebrand Factor | 2002 |
Effects of prostaglandin E1, melatonin, and oxytetracycline on lipid peroxidation, antioxidant defense system, paraoxonase (PON1) activities, and homocysteine levels in an animal model of spinal cord injury.
Topics: Acute Disease; Alprostadil; Animals; Antioxidants; Aryldialkylphosphatase; Biomarkers; Disease Models, Animal; Double-Blind Method; Free Radical Scavengers; Homocysteine; Lipid Peroxidation; Male; Malondialdehyde; Melatonin; Oxidative Stress; Oxytetracycline; Prospective Studies; Random Allocation; Rats; Rats, Wistar; Spinal Cord; Spinal Cord Injuries; Treatment Outcome | 2003 |